ProfileGDS5822 / ILMN_2622146
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 92% 90% 87% 90% 90% 93% 92% 90% 88% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1637.992
GSM1276600PDAC Late Ablation Control 2480.690
GSM1276601PDAC Late Ablation Control 3418.587
GSM1276602PDAC Late Ablation 1469.390
GSM1276603PDAC Late Ablation 2492.690
GSM1276604PDAC Late Ablation 382693
GSM1303940PDAC Late Ablation_anti-CTLA4 1625.992
GSM1303941PDAC Late Ablation_anti-CTLA4 2568.790
GSM1303942PDAC Late Ablation_anti-CTLA4 3453.588